Safety of the new selective cyclooxygenase type 2 inhibitors rofecoxib and celecoxib in patients with anaphylactoid reactions to nonsteroidal anti-inflammatory drugs

Autor: Quiralte, Joaquín, Delgado, Julio, de San Pedro, Blanca Sáenz, López-Pascual, Esperanza, Nieto, Maria A., Ortega, Nancy, Florido, Jose Fernando, Conde, José
Zdroj: In Annals of Allergy, Asthma & Immunology 2004 93(4):360-364
Databáze: ScienceDirect